EUVIMEDEUVIMED entdecken
Open Access

A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation

Jiang Tian, Qinyao Xu, Zexin Wang, Zeyu Wang, Haofang Zhu, Lingyun Sun, Zhongwei Gu

Theranostics · 2026

DOI: 10.7150/thno.136356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Jiang Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Lupus Nephritis, Mesenchymal Stem Cells, Immunomodulation, Mesenchymal Stem Cell Transplantation. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisMesenchymal Stem CellsImmunomodulationMesenchymal Stem Cell TransplantationAnimalsTacrolimusMiceMice, Inbred MRL lprImmunosuppressive AgentsDendrimersFemalePolylysineDisease Models, AnimalHumansDNANanogelsT-LymphocytesKidney

Stichwörter der Autor:innen

MSCscell-free DNAhominglupus nephritispeptide dendrimer

Substanzen

TacrolimusImmunosuppressive AgentsDendrimersPolylysineDNANanogels

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Rheumatology and Immunology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Research Institute for Biomaterials, Tech Institute for Advanced Materials, College of Materials Science and Engineering, Suqian Advanced Materials Industry Technology Innovation Center, Nanjing Tech University, Nanjing…

Zitieren

APA

Tian, J., Xu, Q., Wang, Z., Wang, Z., Zhu, H., Sun, L., & Gu, Z. (2026). A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation. Theranostics. https://doi.org/10.7150/thno.136356

Vancouver

Tian J, Xu Q, Wang Z, Wang Z, Zhu H, Sun L, et al. A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation. Theranostics. 2026. doi:10.7150/thno.136356

BibTeX
@article{Tian2026,
  author = {Tian, Jiang and Xu, Qinyao and Wang, Zexin and Wang, Zeyu and Zhu, Haofang and Sun, Lingyun and Gu, Zhongwei},
  title = {A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.136356}
}
Kostenlos starten →